P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 12.18 CNY 2.01% Market Closed
Market Cap: 4.2B CNY

Intrinsic Value

The intrinsic value of one Pulike Biological Engineering Inc stock under the Base Case scenario is 17.32 CNY. Compared to the current market price of 12.18 CNY, Pulike Biological Engineering Inc is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
17.32 CNY
Undervaluation 30%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Pulike Biological Engineering Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Pulike Biological Engineering Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Pulike Biological Engineering Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Pulike Biological Engineering Inc
SSE:603566
CN
Pharmaceuticals
Market Cap
4.2B CNY
IPO
May 18, 2015
CN
Pharmaceuticals
Market Cap
4.2B CNY
IPO
May 18, 2015
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Pulike Biological Engineering Inc?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Pulike Biological Engineering Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pulike Biological Engineering Inc

Current Assets 1.2B
Cash & Short-Term Investments 508.5m
Receivables 468.9m
Other Current Assets 213.8m
Non-Current Assets 1.9B
Long-Term Investments 353.5m
PP&E 1.2B
Intangibles 293.8m
Other Non-Current Assets 38.3m
Efficiency

Free Cash Flow Analysis
Pulike Biological Engineering Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pulike Biological Engineering Inc

Revenue
1.1B CNY
Cost of Revenue
-429.4m CNY
Gross Profit
656.4m CNY
Operating Expenses
-558.8m CNY
Operating Income
97.7m CNY
Other Expenses
4m CNY
Net Income
101.7m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Pulike Biological Engineering Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Net Income
Positive Revenue Growth Forecast
48/100
Profitability
Score

Pulike Biological Engineering Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Pulike Biological Engineering Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
84/100
Solvency
Score

Pulike Biological Engineering Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Pulike Biological Engineering Inc

Wall Street analysts forecast Pulike Biological Engineering Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pulike Biological Engineering Inc is 15.43 CNY with a low forecast of 15.15 CNY and a high forecast of 16.01 CNY.

Lowest
Price Target
15.15 CNY
24% Upside
Average
Price Target
15.43 CNY
27% Upside
Highest
Price Target
16.01 CNY
31% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Pulike Biological Engineering Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Pulike Biological Engineering Inc stock?

The intrinsic value of one Pulike Biological Engineering Inc stock under the Base Case scenario is 17.32 CNY.

Is Pulike Biological Engineering Inc stock undervalued or overvalued?

Compared to the current market price of 12.18 CNY, Pulike Biological Engineering Inc is Undervalued by 30%.

Back to Top